![High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward NCI’s Youth Enjoy Science (YES) program also invests in student scientists](https://cdn.cancerletter.com/media/2024/06/28142306/50-26-4x3-1.jpg)
![High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward NCI’s Youth Enjoy Science (YES) program also invests in student scientists](https://cdn.cancerletter.com/media/2024/06/28142306/50-26-4x3-1.jpg)
Cover Story
Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Lei Zheng named executive director of Mays Cancer Center
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”